News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter

N-Of-One Executive Joins OBR Oncology Editorial Board As Precision Medicine Section Editor And Contributing Writer

1/29/2014 9:39:37 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LEXINGTON, Mass., January 29, 2014 – N-of-One, Inc., the leading provider of molecular interpretation and therapeutic strategies for precision medicine in cancer care, today announced that Jennifer Levin Carter, MD, PhD, Chief Medical Officer and Founder, has joined the editorial board of Oncology Business Review (OBR), a comprehensive digital platform for oncology-focused news and information, as Precision Medicine Section Editor. Dr. Carter will contribute articles on advances in precision medicine for cancer treatment focused on the point of care, based on N-of-One’s extensive five year experience interpreting more than 6,000 tumors.

Dr. Carter’s first contributed article appeared in the January 2014 issue of OBR Oncology’s monthly publication OBR green:

Three Industry Developments in Precision Medicine in 2013 Set the Stage for Broader Availability

“We are honored to welcome Dr. Carter to our editorial board and as a regular contributor to OBR,” said Don Sharpe, President of OBR. “Our focus at OBR is on providing passionate, expert original coverage of news and trends affecting the oncology field, and as founder of the leading company providing molecular interpretation for personalized cancer medicine, Dr. Carter brings a unique perspective and knowledge to her new role as Precision Medicine Section Editor that will be very valuable to our readers.”

About N-of-One

N-of-One, a leader in precision medicine, leverages its world-class team of experts to translate molecular data specific to each patient into state-of-the-art, clinically actionable insights and therapeutic options focused on the point of care. Using the company’s PrecisionWorks™ knowledge integration platform and framework, N-of-One’s team of experts has delivered more than 6,000 personalized, interpretative roadmaps to oncologists and patients worldwide, through partnerships to provide interpretation services for leading diagnostic companies (such as Foundation Medicine and Clarient), through agreements with provider networks (such as Fox Chase Cancer Center in Philadelphia), directly to oncologists or through employee access benefit programs (such as Life Technologies). N-of-One does not provide medical advice or promote any product or service. For more information, please visit or call 617-202-9808.

Help employers find you! Check out all the jobs and post your resume.

Read at

comments powered by Disqus